J. Heger

发表

Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)

A. Hüttmann, C. Kobe, P. Borchmann, 2021, British journal of haematology.

The Cdkn1aSUPER Mouse as a Tool to Study p53-Mediated Tumor Suppression.

R. Büttner, B. Schumacher, M. Pasparakis, 2018, Cell reports.

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

G. Canonica, T. Zander, N. Adhikari, 2021, The Lancet Respiratory Medicine.

Coming of age: the evolving role of circulating tumor DNA in malignant lymphoma

S. Borchmann, J. Heger, 2022, Leukemia & lymphoma.

Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.

U. Holtick, C. Scheid, P. Borchmann, 2022, Clinical lymphoma, myeloma & leukemia.

JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)

C. Kobe, P. Borchmann, H. Ostermann, 2022, European journal of haematology.

Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis

M. Hallek, A. Shimabukuro-Vornhagen, U. Holtick, 2022, Annals of Hematology.

Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis

J. Mahlich, P. Borchmann, Michael S. Papadimitrious, 2022, Oncology and Therapy.

Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital

M. Hallek, A. Shimabukuro-Vornhagen, U. Holtick, 2021, Annals of Hematology.

Potential synergy between radiotherapy and CAR T-cells - A multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy.

S. Marnitz, Minglun Li, M. von Bergwelt-Baildon, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy

G. Lenz, K. Rahbar, M. Dietlein, 2023, HemaSphere.

Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database

J. Mahlich, P. Borchmann, Michael S. Papadimitrious, 2023, Journal of cancer research and clinical oncology.

Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX‐based regimens in clinical routine

M. Deckert, P. Borchmann, H. Balke-Want, 2021, European journal of haematology.

Hematologic Rescue of CAR T-cell–mediated Prolonged Pancytopenia Using Autologous Peripheral Blood Hematopoietic Stem Cells in a Lymphoma Patient

U. Holtick, C. Scheid, P. Borchmann, 2021, HemaSphere.

Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high‐grade B‐cell lymphoma

P. Borchmann, H. Balke-Want, J. Naendrup, 2022, European journal of haematology.

Clinical applications of circulating tumor DNA in Hodgkin lymphoma.

J. Ferdinandus, S. Borchmann, J. Heger, 2023, Seminars in hematology.

P037: High breadth whole exome sequencing of circulating tumor DNA identifies novel recurrent genetic alterations in Hodgkin lymphoma

J. Altmüller, P. Borchmann, A. Engert, 2022, HemaSphere.

Characteristics, outcomes and health care utilization of patients with acute myeloid leukemia aged 70 years or older: A single-center retrospective analysis.

D. Eichenauer, N. Sieg, Marie Anne-Catherine Neumann, 2024, Hematological oncology.